Lisa J.  Bergersen

Lisa J. Bergersen, MD, MPH

Associate in Cardiology

Associate Professor of Pediatrics, Harvard Medical School

  • Contact: 617-355-6529

  • Fax: 617-730-7548

"It is my strong belief that the role of a physician is not only to be responsible for the treatment and management of a patient’s care, but also to ease the difficult situations faced by patients and their families through honest conversation and unwavering support."

Medical Services

Specialties

  • Interventional Catheterization
  • Cardiology

Departments

  • Cardiology
  • Cardiovascular Program

Programs

  • Cardiac Catheterization Labs
  • Congenital Heart Valve Program
To schedule an appointment: Call 617-355-6529 or Request an Appointment
Lisa J.  Bergersen

My early fascination with studying human anatomy and my desire to work directly with people to improve their well-being inspired me to pursue a career in medicine.  

Now, as a practicing pediatric interventional cardiologist, I not only explore my interests in cardiology and participate in the direct care of patients every day, but I also contribute my own thoughts to current practices in order to advance the field. This iterative process of medicine frequently challenges me to adapt my own practices as a physician to improve the quality of care used to treat patients. It is my strong belief that the role of a physician is not only to be responsible for the treatment and management of a patient’s care, but also to ease the difficult situations faced by patients and their families through honest conversation and unwavering support.

Experience and Education

Education

Medical Degree

University of Vermont College of Medicine, 1996

Burlington, VT

Residency

St. Louis Children's Hospital, 1999

St. Louis, MO

Fellowship

Boston Children's Hospital, 2004

Boston , MA

Certifications

  • Pediatrics, Pediatric Cardiology

Professional History

Dr. Lisa Bergersen is an Associate Professor of Pediatrics at Harvard Medical School and an Interventional Cardiologist in the Department of Cardiology at Boston Children’s Hospital (BCH). After graduating from the University of Vermont College of Medicine, she completed her pediatrics residency at St. Louis Children’s Hospital in Missouri. Dr. Bergersen pursued further training at BCH as a Fellow in pediatric cardiology, serving as Chief Fellow in 2003 before finishing her specialized training in interventional catheterization in 2004. While practicing medicine full time at BCH, Dr. Bergersen obtained a Master’s in Public Health at the Harvard School of Public Health. She has used her expertise in this area to establish patient safety and quality improvement projects in hospitals nationwide. In 2012, Dr. Bergersen pioneered the development of the first multi-center registry to record procedural and outcome measures. The project is currently instituting many important quality improvement initiatives in the field, such as reducing patient radiation exposure. In addition to serving as Principal Investigator on several cutting-edge clinical device studies, Dr. Bergersen is an established writer, having published extensively in pediatric interventional cardiology and co-authoring the leading catheterization manual used for training in the field.

Publications

Publications powered by Harvard Catalyst Profiles
  1. Nathan M, Gauvreau K, Samnaliev M, Ozonoff A, Jenkins K, Bergersen L, Connor J, Pigula FA, Colan SD, Mayer JE, Del Nido PJ. Technical Performance Score Predicts Resource Utilization in Congenital Cardiac Procedures. J Am Coll Cardiol. 2016 Jun 7; 67(22):2696-8.
  2. Mills KI, Vincent JA, Zuckerman WA, Hoffman TM, Canter CE, Marshall AC, Blume ED, Bergersen L, Daly KP. Is Endomyocardial Biopsy a Safe and Useful Procedure in Children with Suspected Cardiomyopathy? Pediatr Cardiol. 2016 Oct; 37(7):1200-10.
  3. Jayaram N, Beekman RH, Benson L, Holzer R, Jenkins K, Kennedy KF, Martin GR, Moore JW, Ringel R, Rome J, Spertus JA, Vincent R, Bergersen L. Adjusting for Risk Associated With Pediatric and Congenital Cardiac Catheterization: A Report From the NCDR IMPACT Registry. Circulation. 2015 Nov 17; 132(20):1863-70.
  4. Holzer R, Beekman R, Benson L, Bergersen L, Jayaram N, Jenkins K, Kennedy K, Moore J, Ringel R, Rome J, Vincent R, Martin GR. Characteristics and safety of interventions and procedures performed during catheterisation of patients with congenital heart disease: early report from the national cardiovascular data registry. Cardiol Young. 2016 Aug; 26(6):1202-12.
  5. Goldstein BH, Holzer RJ, Trucco SM, Porras D, Murphy J, Foerster SR, El-Said HG, Beekman RH, Bergersen L. Practice Variation in Single-Ventricle Patients Undergoing Elective Cardiac Catheterization: A Report from the Congenital Cardiac Catheterization Project on Outcomes (C3PO). Congenit Heart Dis. 2016 Mar-Apr; 11(2):122-35.
  6. Torres A, Vincent JA, Everett A, Lim S, Foerster SR, Marshall AC, Beekman RH, Murphy J, Trucco SM, Gauvreau K, Holzer R, Bergersen L, Porras D. Balloon valvuloplasty for congenital aortic stenosis: Multi-center safety and efficacy outcome assessment. Catheter Cardiovasc Interv. 2015 Nov; 86(5):808-20.
  7. Lin CH, Desai S, Nicolas R, Gauvreau K, Foerster S, Sharma A, Armsby L, Marshall AC, Odegard K, DiNardo J, Vincent J, El-Said H, Spaeth J, Goldstein B, Holzer R, Kreutzer J, Balzer D, Bergersen L. Sedation and Anesthesia in Pediatric and Congenital Cardiac Catheterization: A Prospective Multicenter Experience. Pediatr Cardiol. 2015 Oct; 36(7):1363-75.
  8. Esch JJ, Porras D, Bergersen L, Jenkins KJ, Marshall AC. Systemic Embolic Complications of Pulmonary Vein Angioplasty in Children. Pediatr Cardiol. 2015 Oct; 36(7):1357-62.
  9. Vincent RN, Moore J, Beekman RH, Benson L, Bergersen L, Holzer R, Jayaram N, Jenkins K, Ringel R, Rome J, Martin GR. Procedural characteristics and adverse events in diagnostic and interventional catheterisations in paediatric and adult CHD: initial report from the IMPACT Registry. Cardiol Young. 2016 Jan; 26(1):70-8.
  10. Chaudhry-Waterman N, Bergersen L, Buber J. Bacterial Endocarditis Manifesting as Outflow Tract Obstruction in Two Patients Implanted With Percutaneous Prosthetic Pulmonary Valves. Can J Cardiol. 2015 Sep; 31(9):1204.e1-3.
  11. Show all
  12. Bergersen L, Brennan A, Gauvreau K, Connor J, Almodovar M, DiNardo J, David S, Triedman J, Banka P, Emani S, Mayer JE. A method to account for variation in congenital heart surgery charges. Ann Thorac Surg. 2015 Mar; 99(3):939-46.
  13. Moore JW, Vincent RN, Beekman RH, Benson L, Bergersen L, Holzer R, Jayaram N, Jenkins K, Li Y, Ringel R, Rome J, Martin GR. Procedural results and safety of common interventional procedures in congenital heart disease: initial report from the National Cardiovascular Data Registry. J Am Coll Cardiol. 2014 Dec 16; 64(23):2439-51.
  14. El-Said H, Hegde S, Foerster S, Hellenbrand W, Kreutzer J, Trucco SM, Holzer R, Burch G, Mirani A, Nicolas R, Porras D, Bergersen L, Moore J. Device therapy for atrial septal defects in a multicenter cohort: acute outcomes and adverse events. Catheter Cardiovasc Interv. 2015 Feb 1; 85(2):227-33.
  15. Backes CH, Bergersen L, Rome JJ, Batlivala SP, Glatz AC, Ovunc B, David S, Rivera BK, Haque U, Kollins K, Yin H, Holzer RJ. Quality metrics in cardiac catheterization for congenital heart disease: utility of 30-day mortality. Catheter Cardiovasc Interv. 2015 Jan 1; 85(1):104-10.
  16. Ghelani SJ, Glatz AC, David S, Leahy R, Hirsch R, Armsby LB, Trucco SM, Holzer RJ, Bergersen L. Radiation dose benchmarks during cardiac catheterization for congenital heart disease in the United States. JACC Cardiovasc Interv. 2014 Sep; 7(9):1060-9.
  17. Brennan A, Gauvreau K, Connor J, O'Connell C, David S, Almodovar M, DiNardo J, Banka P, Mayer JE, Marshall AC, Bergersen L. Development of a charge adjustment model for cardiac catheterization. Pediatr Cardiol. 2015 Feb; 36(2):264-73.
  18. Morray BH, Bergersen L, Lock JE, Marshall AC. Occult progressive pulmonary arterial occlusion associated with right ventricular hypertension in patients with systemic arteriopathy. Congenit Heart Dis. 2015 Mar-Apr; 10(2):E60-7.
  19. Chaudhry-Waterman N, Coombs S, Porras D, Holzer R, Bergersen L. Developing tools to measure quality in congenital catheterization and interventions: the congenital cardiac catheterization project on outcomes (C3PO). Methodist Debakey Cardiovasc J. 2014 Apr-Jun; 10(2):63-7.
  20. Odegard KC, Bergersen L, Thiagarajan R, Clark L, Shukla A, Wypij D, Laussen PC. The frequency of cardiac arrests in patients with congenital heart disease undergoing cardiac catheterization. Anesth Analg. 2014 Jan; 118(1):175-82.
  21. Mah DY, Porras D, Bergersen L, Marshall AC, Walsh EP, Triedman JK. Incidence of and risk factors for catheterization-induced complete heart block in the pediatric cardiac catheterization laboratory. Circ Arrhythm Electrophysiol. 2014 Feb; 7(1):127-33.
  22. Aiyagari R, Rhodes JF, Shrader P, Radtke WA, Bandisode VM, Bergersen L, Gillespie MJ, Gray RG, Guey LT, Hill KD, Hirsch R, Kim DW, Lee KJ, Pelech AN, Ringewald J, Takao C, Vincent JA, Ohye RG. Impact of pre-stage II hemodynamics and pulmonary artery anatomy on 12-month outcomes in the Pediatric Heart Network Single Ventricle Reconstruction trial. J Thorac Cardiovasc Surg. 2014 Oct; 148(4):1467-74.
  23. El-Said HG, Bratincsak A, Foerster SR, Murphy JJ, Vincent J, Holzer R, Porras D, Moore J, Bergersen L. Safety of percutaneous patent ductus arteriosus closure: an unselected multicenter population experience. J Am Heart Assoc. 2013; 2(6):e000424.
  24. Porras D, Brown DW, Rathod R, Friedman K, Gauvreau K, Lock JE, Esch JJ, Bergersen L, Marshall AC. Acute outcomes after introduction of a standardized clinical assessment and management plan (SCAMP) for balloon aortic valvuloplasty in congenital aortic stenosis. Congenit Heart Dis. 2014 Jul-Aug; 9(4):316-25.
  25. Cunningham JW, McElhinney DB, Gauvreau K, Bergersen L, Lacro RV, Marshall AC, Smoot L, Lock JE. Outcomes after primary transcatheter therapy in infants and young children with severe bilateral peripheral pulmonary artery stenosis. Circ Cardiovasc Interv. 2013 Aug; 6(4):460-7.
  26. Lin CH, Hegde S, Marshall AC, Porras D, Gauvreau K, Balzer DT, Beekman RH, Torres A, Vincent JA, Moore JW, Holzer R, Armsby L, Bergersen L. Incidence and management of life-threatening adverse events during cardiac catheterization for congenital heart disease. Pediatr Cardiol. 2014 Jan; 35(1):140-8.
  27. Hill KD, Rhodes JF, Aiyagari R, Baker GH, Bergersen L, Chai PJ, Fleming GA, Fudge JC, Gillespie MJ, Gray RG, Hirsch R, Lee KJ, Li JS, Ohye RG, Oster ME, Pasquali SK, Pelech AN, Radtke WA, Takao CM, Vincent JA, Hornik CP. Intervention for recoarctation in the single ventricle reconstruction trial: incidence, risk, and outcomes. Circulation. 2013 Aug 27; 128(9):954-61.
  28. Buber J, Bergersen L, Lock JE, Gauvreau K, Esch JJ, Landzberg MJ, Valente AM, Sandora TJ, Marshall AC. Bloodstream infections occurring in patients with percutaneously implanted bioprosthetic pulmonary valve: a single-center experience. Circ Cardiovasc Interv. 2013 Jun; 6(3):301-10.
  29. Moore J, Hegde S, El-Said H, Beekman R, Benson L, Bergersen L, Holzer R, Jenkins K, Ringel R, Rome J, Vincent R, Martin G. Transcatheter device closure of atrial septal defects: a safety review. JACC Cardiovasc Interv. 2013 May; 6(5):433-42.
  30. Holzer RJ, Gauvreau K, Kreutzer J, Moore JW, McElhinney DB, Bergersen L. Relationship between procedural adverse events associated with cardiac catheterization for congenital heart disease and operator factors: results of a multi-institutional registry (C3PO). Catheter Cardiovasc Interv. 2013 Sep 1; 82(3):463-73.
  31. Backes CH, Cua C, Kreutzer J, Armsby L, El-Said H, Moore JW, Gauvreau K, Bergersen L, Holzer RJ. Low weight as an independent risk factor for adverse events during cardiac catheterization of infants. Catheter Cardiovasc Interv. 2013 Nov 1; 82(5):786-94.
  32. Mets JM, Bergersen L, Mayer JE, Marshall AC, McElhinney DB. Outcomes of stent implantation for obstruction of intracardiac lateral tunnel Fontan pathways. Circ Cardiovasc Interv. 2013 Feb; 6(1):92-100.
  33. Learn CP, Holzer RJ, Daniels CJ, Torres AJ, Vincent JA, Moore JW, Armsby LB, Landzberg MJ, Bergersen L. Adverse events rates and risk factors in adults undergoing cardiac catheterization at pediatric hospitals--results from the C3PO. Catheter Cardiovasc Interv. 2013 May; 81(6):997-1005.
  34. Bergersen L, Gauvreau K, McElhinney D, Fenwick S, Kirshner D, Harding J, Hickey P, Mayer J, Marshall A. Capture of complexity of specialty care in pediatric cardiology by work RVU measures. Pediatrics. 2013 Feb; 131(2):258-67.
  35. Kazanci SY, McElhinney DB, Thiagarajan R, Bergersen L, Wilson JM, Marshall AC, Lock JE, Mullen MP. Obstruction of the superior vena cava after neonatal extracorporeal membrane oxygenation: association with chylothorax and outcome of transcatheter treatment. Pediatr Crit Care Med. 2013 Jan; 14(1):37-43.
  36. Esch JJ, Bergersen L, McElhinney DB, Porras D, Lock JE, Marshall AC. Wire-related pulmonary artery injury during pediatric and adult congenital interventional cardiac catheterization. Congenit Heart Dis. 2013 Jul-Aug; 8(4):296-301.
  37. Carr M, Bergersen L, Marshall AC, Keane JF, Lock JE, Emani SM, McElhinney DB. Bare metal stenting for obstructed small diameter homograft conduits in the right ventricular outflow tract. Catheter Cardiovasc Interv. 2013 Jan 1; 81(1):E44-52.
  38. Holzer RJ, Gauvreau K, Kreutzer J, Trucco SM, Torres A, Shahanavaz S, Bergersen L. Safety and efficacy of balloon pulmonary valvuloplasty: a multicenter experience. Catheter Cardiovasc Interv. 2012 Oct 1; 80(4):663-72.
  39. Chen MH, Abernathey E, Lunze F, Colan SD, O'Neill S, Bergersen L, Geva T, Blume ED. Utility of exercise stress echocardiography in pediatric cardiac transplant recipients: a single-center experience. J Heart Lung Transplant. 2012 May; 31(5):517-23.
  40. Daly KP, Marshall AC, Vincent JA, Zuckerman WA, Hoffman TM, Canter CE, Blume ED, Bergersen L. Endomyocardial biopsy and selective coronary angiography are low-risk procedures in pediatric heart transplant recipients: results of a multicenter experience. J Heart Lung Transplant. 2012 Apr; 31(4):398-409.
  41. Verghese GR, McElhinney DB, Strauss KJ, Bergersen L. Characterization of radiation exposure and effect of a radiation monitoring policy in a large volume pediatric cardiac catheterization lab. Catheter Cardiovasc Interv. 2012 Feb 1; 79(2):294-301.
  42. Bergersen L, Gauvreau K, Justino H, Nugent A, Rome J, Kreutzer J, Rhodes J, Nykanen D, Zahn E, Latson L, Moore P, Lock J, Jenkins K. Randomized trial of cutting balloon compared with high-pressure angioplasty for the treatment of resistant pulmonary artery stenosis. Circulation. 2011 Nov 29; 124(22):2388-96.
  43. Saleeb SF, Margossian R, Spencer CT, Alexander ME, Smoot LB, Dorfman AL, Bergersen L, Gauvreau K, Marx GR, Colan SD. Reproducibility of echocardiographic diagnosis of left ventricular noncompaction. J Am Soc Echocardiogr. 2012 Feb; 25(2):194-202.
  44. Bergersen L, Gauvreau K, Foerster SR, Marshall AC, McElhinney DB, Beekman RH, Hirsch R, Kreutzer J, Balzer D, Vincent J, Hellenbrand WE, Holzer R, Cheatham JP, Moore JW, Burch G, Armsby L, Lock JE, Jenkins KJ. Catheterization for Congenital Heart Disease Adjustment for Risk Method (CHARM). JACC Cardiovasc Interv. 2011 Sep; 4(9):1037-46.
  45. Holzer RJ, Gauvreau K, Kreutzer J, Leahy R, Murphy J, Lock JE, Cheatham JP, Bergersen L. Balloon angioplasty and stenting of branch pulmonary arteries: adverse events and procedural characteristics: results of a multi-institutional registry. Circ Cardiovasc Interv. 2011 Jun; 4(3):287-96.
  46. Bergersen L, Gauvreau K, Marshall A, Kreutzer J, Beekman R, Hirsch R, Foerster S, Balzer D, Vincent J, Hellenbrand W, Holzer R, Cheatham J, Moore J, Lock J, Jenkins K. Procedure-type risk categories for pediatric and congenital cardiac catheterization. Circ Cardiovasc Interv. 2011 Apr 1; 4(2):188-94.
  47. Bergersen L, Everett AD, Giroud JM, Martin GR, Franklin RC, Béland MJ, Krogmann ON, Aiello VD, Colan SD, Elliott MJ, Gaynor JW, Kurosawa H, Maruszewski B, Stellin G, Tchervenkov CI, Walters HL, Weinberg P, Jacobs JP. Report from The International Society for Nomenclature of Paediatric and Congenital Heart Disease: cardiovascular catheterisation for congenital and paediatric cardiac disease (Part 1 - Procedural nomenclature). Cardiol Young. 2011 Jun; 21(3):252-9.
  48. Bergersen L, Giroud JM, Jacobs JP, Franklin RC, Béland MJ, Krogmann ON, Aiello VD, Colan SD, Elliott MJ, Gaynor JW, Kurosawa H, Maruszewski B, Stellin G, Tchervenkov CI, Walters HL, Weinberg P, Everett AD. Report from The International Society for Nomenclature of Paediatric and Congenital Heart Disease: cardiovascular catheterisation for congenital and paediatric cardiac disease (Part 2 - Nomenclature of complications associated with interventional cardiology). Cardiol Young. 2011 Jun; 21(3):260-5.
  49. Shuhaiber JH, Bergersen L, Pigula F, Emani S, McElhinney D, Marshall A, Fynn-Thompson F, Bacha EA. Intraoperative assessment after pediatric cardiac surgical repair: initial experience with C-arm angiography. J Thorac Cardiovasc Surg. 2010 Jul; 140(1):e1-3.
  50. Goldstein BH, Bergersen L, Powell AJ, Graham DA, Bacha EA, Lang P. Long-term outcome of surgically repaired unilateral anomalous pulmonary artery origin. Pediatr Cardiol. 2010 Oct; 31(7):944-51.
  51. Bergersen L, Marshall A, Gauvreau K, Beekman R, Hirsch R, Foerster S, Balzer D, Vincent J, Hellenbrand W, Holzer R, Cheatham J, Moore J, Lock J, Jenkins K. Adverse event rates in congenital cardiac catheterization - a multi-center experience. Catheter Cardiovasc Interv. 2010 Feb 15; 75(3):389-400.
  52. Ralf Holzer, MD, Audrey Marshall, MD, Jackie Kreutzer, MD, Russel Hirsch, MD, Joanne Chisolm, RN, Sharon Hill, ACNP, Mark Galantowicz, MD, Alistair Phillips, MD, John Cheatham, MD, and Lisa Bergerson, MD. Hybrid Procedures: Adverse Events and Procedural Characteristics—Results of a Multi-institutional Registry. Congenital Heart Disease 2010. 2010; 5:233-242.
  53. Senthilnathan S, Gauvreau K, Marshall AC, Lock JE, Bergersen L. Contrast administration in pediatric cardiac catheterization: dose and adverse events. Catheter Cardiovasc Interv. 2009 May 1; 73(6):814-20.
  54. Bergersen L, Foerster S, Marshall AC, Meadows J. Congenital Heart Disease: The Catheterization Manual. 2009.
  55. Maglione J, Bergersen L, Lock JE, McElhinney DB. Ultra-high-pressure balloon angioplasty for treatment of resistant stenoses within or adjacent to previously implanted pulmonary arterial stents. Circ Cardiovasc Interv. 2009 Feb; 2(1):52-8.
  56. Jenkins KJ, Beekman Iii RH, Bergersen LJ, Everett AD, Forbes TJ, Franklin RC, Klitzner TS, Krogman ON, Martin GR, Webb CL. Databases for assessing the outcomes of the treatment of patients with congenital and paediatric cardiac disease--the perspective of cardiology. Cardiol Young. 2008 Dec; 18 Suppl 2:116-23.
  57. Larrazabal LA, Selamet Tierney ES, Brown DW, Gauvreau K, Vida VL, Bergersen L, Pigula FA, del Nido PJ, Bacha EA. Ventricular function deteriorates with recurrent coarctation in hypoplastic left heart syndrome. Ann Thorac Surg. 2008 Sep; 86(3):869-74; discussion 869-74.
  58. Bergersen L, Gauvreau K, Lock JE, Jenkins KJ. A risk adjusted method for comparing adverse outcomes among practitioners in pediatric and congenital cardiac catheterization. Congenit Heart Dis. 2008 Jul-Aug; 3(4):230-40.
  59. McElhinney DB, Bergersen L, Marshall AC. In situ fracture of stents implanted for relief of pulmonary arterial stenosis in patients with congenitally malformed hearts. Cardiol Young. 2008 Aug; 18(4):405-14.
  60. Bergersen L, Gauvreau K, Jenkins KJ, Lock JE. Adverse event rates in congenital cardiac catheterization: a new understanding of risks. Congenit Heart Dis. 2008 Mar-Apr; 3(2):90-105.
  61. Selvi Senthilnathan, Kimberlee Gauvreau, James E. Lock, Lisa Bergersen. Adverse Events Attributable to Contrast Administration in Pediatric Cardiac Catheterization. Abstract presented at the ACC annual meeting. 2008.
  62. Jenkins K, Beekman R, Bergersen L, Everett A, Forbes T, Franklin R, Klitzner T, Krogman O, Martin G, Webb C. Databases for assessing the outcomes of the treatment of patients with congenital and pediatric cardica disease - the perspective of cardiology. Cardiol Young. 2008; 18(Suppl. 2):116-123.
  63. Bergersen L, Lock JE. What is the current option of first choice for treatment of pulmonary arterial stenosis? Cardiol Young. 2006 Aug; 16(4):329-38.
  64. Bergersen L, Lock J. Pulmonary artery stenosis, angioplasty, stenting, or cutting balloon: what is the current treatment of first choice? A review. Cardiol Young. 2006; 16:1-10.
  65. Bergersen L, Jenkins KJ, Gauvreau K, Lock JE. Follow-up results of Cutting Balloon angioplasty used to relieve stenoses in small pulmonary arteries. Cardiol Young. 2005 Dec; 15(6):605-10.
  66. Bergersen L, Gauvreau K, Lock JE, Jenkins KJ. Recent results of pulmonary arterial angioplasty: the differences between proximal and distal lesions. Cardiol Young. 2005 Dec; 15(6):597-604.
  67. Marshall AC, Tworetzky W, Bergersen L, McElhinney DB, Benson CB, Jennings RW, Wilkins-Haug LE, Marx GR, Lock JE. Aortic valvuloplasty in the fetus: technical characteristics of successful balloon dilation. J Pediatr. 2005 Oct; 147(4):535-9.
  68. Marshall A, Tworetzky W, Bergersen L, McElhinney D, Benson C, Jennings R, Wilkins-Haus L, Marx G, Lock J. Aortic valvuloplasty in the fetus: technical characteristics of successful balloon dilation. J Peds. 2005; 147:535-9.
  69. Bergersen LJ, Perry SB, Lock JE. Effect of cutting balloon angioplasty on resistant pulmonary artery stenosis. Am J Cardiol. 2003 Jan 15; 91(2):185-9.
  70. Johnson MC, Bergersen LJ, Beck A, Dick G, Cole BR. Diastolic function and tachycardia in hypertensive children. Am J Hypertens. 1999 Oct; 12(10 Pt 1):1009-14.
  71. Bergersen L, Kiernan MS, McFarlane G, Case TD, Ricci MA. Prevalence of abdominal aortic aneurysms in patients undergoing coronary artery bypass. Ann Vasc Surg. 1998 Mar; 12(2):101-5.
  72. Ricci MA, Strindberg G, Slaiby JM, Guibord R, Bergersen LJ, Nichols P, Hendley ED, Pilcher DB. Anti-CD 18 monoclonal antibody slows experimental aortic aneurysm expansion. J Vasc Surg. 1996 Feb; 23(2):301-7.
To schedule an appointment: Call 617-355-6529 or Request an Appointment

Locations

We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944

Close